Population-based study of the durability of humoral immunity after SARS-CoV-2 infection

Peterhoff D, Wiegrebe S, Einhauser S, Patt AJ, Beileke S, Günther F, Steininger P, Niller HH, Burkhardt R, Küchenhoff H, Gefeller O, Überla K, Heid IM, Wagner R (2023)


Publication Type: Journal article

Publication year: 2023

Journal

Book Volume: 14

Article Number: 1242536

DOI: 10.3389/fimmu.2023.1242536

Abstract

SARS-CoV-2 antibody quantity and quality are key markers of humoral immunity. However, there is substantial uncertainty about their durability. We investigated levels and temporal change of SARS-CoV-2 antibody quantity and quality. We analyzed sera (8 binding, 4 avidity assays for spike-(S-)protein and nucleocapsid-(N-)protein; neutralization) from 211 seropositive unvaccinated participants, from the population-based longitudinal TiKoCo study, at three time points within one year after infection with the ancestral SARS-CoV-2 virus. We found a significant decline of neutralization titers and binding antibody levels in most assays (linear mixed regression model, p<0.01). S-specific serum avidity increased markedly over time, in contrast to N-specific. Binding antibody levels were higher in older versus younger participants – a difference that disappeared for the asymptomatic-infected. We found stronger antibody decline in men versus women and lower binding and avidity levels in current versus never-smokers. Our comprehensive longitudinal analyses across 13 antibody assays suggest decreased neutralization-based protection and prolonged affinity maturation within one year after infection.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Peterhoff, D., Wiegrebe, S., Einhauser, S., Patt, A.J., Beileke, S., Günther, F.,... Wagner, R. (2023). Population-based study of the durability of humoral immunity after SARS-CoV-2 infection. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1242536

MLA:

Peterhoff, David, et al. "Population-based study of the durability of humoral immunity after SARS-CoV-2 infection." Frontiers in Immunology 14 (2023).

BibTeX: Download